CSTL

NASDAQ 已收盘

Castle Biosciences

33.41 USD
▲+0.02+0.07%
盘后 32.75 -1.96%
2026-11-19
市值
$1.01B
市盈率
—
EPS
-0.77
股息率
—
52 周区间
17.72 – 44.28
成交量
482.43K
Beta
0.95
目标价
48.20
52W 低 17.7252W 高 44.28
价格走势

公司简介

Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), atopic dermatitis (AD), and uveal melanoma. The company offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test that predicts the likelihood of a positive sentinel lymph node and the risk of metastasis for patients with invasive cutaneous melanoma; TissueCypher, a risk stratification spatialomics test to predict future development of high-grade dysplasi...